Creo Medical Share Price (CREO)

Topped up this morning following Chairman's buy and acquistion as I really think this company has reached a tipping point with numerous positive developments this year and hopefully more to come. However my buy is shown as a sell due to large spread quoted. Everything above 205 is a buy in my opinion but they are all shown as sells because they are below the midway point of the spread (202/210). Perhaps MMs trying to persuade the weak to sell by making it look everybody is selling when this is not the case.
Gla, CY

Charles Spicer, Chairman of Creo, today purchased 24,509 ordinary shares of £0.001 each in the capital of the Company ('Ordinary Shares') via his Self-Invested Personal Pension ('SIPP') at a price of 204 pence per Ordinary Share.

This is good news: Acquisition of Albyn Medical S.L.
Supplier of specialist healthcare products adds European commercial platform to Creo

not invested here but just come across this,https://www.gov.uk/government/news/welsh-secretary-visits-company-developing-covid-19-beating-technology

What a strange RNS from the perspective that it misses on the key information you’d expect to see when reporting a material new loan - repayment terms, interest rate and covenants.

Given the equity raise last year, can’t see how this is required now. Potentially gives a faster route to market with contacts and their support. I can only see this as positive given the additional due diligence over the product by the CCR - and perhaps indicates that going forward any capital requirements may be fulfilled by the board by the debt market (cheap) as opposed to equity markets.